These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33960690)
1. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis. Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690 [TBL] [Abstract][Full Text] [Related]
2. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP; Clarke CA; Aroner S; Swetter SM J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559 [TBL] [Abstract][Full Text] [Related]
3. Second primary anal and oropharyngeal cancers in cervical cancer survivors. Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108 [TBL] [Abstract][Full Text] [Related]
4. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Nelson RA; Lai LL Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917 [TBL] [Abstract][Full Text] [Related]
5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Jain KS; Sikora AG; Baxi SS; Morris LG Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883 [TBL] [Abstract][Full Text] [Related]
6. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study. Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301 [TBL] [Abstract][Full Text] [Related]
7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study. Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798 [TBL] [Abstract][Full Text] [Related]
9. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? Wu GX; Nelson RA; Kim JY; Raz DJ Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093 [TBL] [Abstract][Full Text] [Related]
10. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995. Cannon MJ; Flanders WD; Pellett PE Int J Cancer; 2000 Feb; 85(4):453-6. PubMed ID: 10699913 [TBL] [Abstract][Full Text] [Related]
12. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129 [TBL] [Abstract][Full Text] [Related]
13. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database. Bu X; Wang X; Wei L; Liu J; Chen M Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531 [TBL] [Abstract][Full Text] [Related]
14. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma. Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437 [TBL] [Abstract][Full Text] [Related]
15. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study. Shah BK; Khanal A Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107 [TBL] [Abstract][Full Text] [Related]
16. Incidence of invasive cancers following squamous cell skin cancer. Levi F; Randimbison L; La Vecchia C; Erler G; Te VC Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621 [TBL] [Abstract][Full Text] [Related]
17. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131 [TBL] [Abstract][Full Text] [Related]
18. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program. Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260 [TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis. Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785 [TBL] [Abstract][Full Text] [Related]
20. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]